“Adaptive pathways” to drug authorisation: adapting to industry?

Courtney Davis, Joel Lexchin, Tom Jefferson, Peter Gøtzsche, Martin McKee

Research output: Contribution to journalComment/debatepeer-review

42 Citations (Scopus)
353 Downloads (Pure)


Evidence for benefits to patients and public health of adaptive pathways is lacking or contradictory, say Courtney Davis and colleagues
Original languageEnglish
Article numberi4437
JournalBritish Medical Journal
Early online date16 Aug 2016
Publication statusE-pub ahead of print - 16 Aug 2016


Dive into the research topics of '“Adaptive pathways” to drug authorisation: adapting to industry?'. Together they form a unique fingerprint.

Cite this